InMode Ltd. to Showcase Innovative Medical Technologies at Investment Conferences

InMode Ltd. to Participate in Upcoming Investor Conferences

InMode Ltd., a prominent global player in the medical technology sector, has announced its participation in several investor conferences scheduled for November 2025. The company's focus on innovative solutions in the medical field will be a key highlight of these events.

Upcoming Conferences

1. UBS Global Healthcare Conference
- Date: Monday, November 10, 2025
- Presenter: Yair Malca, Chief Financial Officer
- Location: Palm Beach Gardens, FL
- Format: In-person one-on-one meetings

2. Jefferies Global Healthcare Conference
- Date: Tuesday, November 18, 2025
- Presenter: Moshe Mizrahy, Chief Executive Officer
- Location: London, U.K.
- Format: In-person fireside chat moderated by Matt Taylor
- Time: 4:00 PM GMT

3. Canaccord Genuity MedTech, Diagnostics and Digital Health Services Forum
- Date: Thursday, November 20, 2025
- Presenter: Yair Malca, Chief Financial Officer
- Location: New York, NY
- Format: In-person one-on-one meetings

These investor conferences provide InMode with an opportunity to engage directly with institutional investors and industry stakeholders while showcasing its latest advancements in the medical technology sector.

About InMode Ltd.

InMode is recognized for its pioneering contributions to minimally invasive medical technologies. By harnessing advanced radiofrequency (RF) technology, InMode develops and markets devices aimed at enhancing both existing medical procedures and emerging surgical techniques.

The company has built a robust portfolio of products that cater to various medical fields, including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. This diverse range of applications highlights InMode's commitment to improving patient outcomes and streamlining surgical processes.

To learn more about InMode and its array of innovative technologies, healthcare enthusiasts and investors can visit their official website at www.inmodemd.com.

Conclusion

InMode Ltd.'s participation in these strategic investor conferences is a testament to its position as a leader in medical innovation. As the company continues to grow and evolve, its focus on advancing medical technologies is evident in its proactive approach to investor relations. Stakeholders are encouraged to attend these conferences to gain deeper insights into the company's future directions and technological advancements.

For additional information or inquiries, interested parties can contact investor relations representative Miri Segal-Scharia at MS-IR LLC via email.